1

Syneos Health

#2727

Rank

$4.39B

Marketcap

US United States

Country

Syneos Health
Leadership team

Ms. Michelle Keefe (CEO & Director)

Mr. Jason M. Meggs (Chief Financial Officer)

Mr. Michael Lee Brooks (Chief Operating Officer)

Products/ Services
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Number of Employees
20,000 - 50,000
Headquarters
Morrisville, North Carolina, United States
Established
1985
Company Registration
SEC CIK number: 0001610950
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
SYNH
Social Media
Overview
Location
Summary
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
History

Syneos Health was formed in 2017 through the merger of two powerhouse companies—INC Research and inVentiv Health—and is now one of the largest biopharmaceutical solutions companies in the world.

Mission
Syneos Health fully expresses our value proposition – that is, our ability to deliver integrated end-to-end solutions and create new paths for our customers to develop and commercialize their therapies.
Vision
Syneos Health’s vision is to win with customers and be the most trusted partner in biopharmaceutical solutions.
Key Team

Mr. Jonathan Olefson (Gen. Counsel & Corp. Sec.)

Mr. Alistair Macdonald (Advisor)

Ms. Donna Hildebrand Kralowetz (Sr. VP of Fin. & Chief Accounting Officer)

Mr. Larry A. Pickett Jr. (Chief Information & Digital Officer)

Mr. Baba Shetty (Pres of Technology & Data Solutions)

Dr. Judith Ng-Cashin M.D. (Chief Scientific Officer)

Ronnie Speight (Sr. VP of Investor Relations)

Recognition and Awards
Syneos Health is proud to have won many awards and titles, including the WorldatWork 2020 Seal of Distinction, the Healthiest Employers in Virginia award from Virginia Business Magazine, and the Healthiest Employers of Dallas-Fort Worth award from the Dallas Business Journal.
References
Syneos Health
Leadership team

Ms. Michelle Keefe (CEO & Director)

Mr. Jason M. Meggs (Chief Financial Officer)

Mr. Michael Lee Brooks (Chief Operating Officer)

Products/ Services
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Number of Employees
20,000 - 50,000
Headquarters
Morrisville, North Carolina, United States
Established
1985
Company Registration
SEC CIK number: 0001610950
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
SYNH
Social Media